Sort
30,917 grants matching “tumor microenvironment”
Inhibition of Stat3 and inflammatory cytokine production
$440,000Lionel B Ivashkiv · Hospital For Special Surgery · R01 · FY2017 · AI
Inhibition of Stat3 and inflammatory cytokine production
$440,000Lionel B Ivashkiv · Hospital For Special Surgery · R01 · FY2016 · AI
Inhibition of Stat3 and inflammatory cytokine production
$440,000Lionel B Ivashkiv · Hospital For Special Surgery · R01 · FY2018 · AI
Comprehensive characterization of prostate stromal gene expression and association with lethal prostate cancer
$439,959Brenda M Birmann · Brigham And Women'S Hospital · R37 · FY2024 · CA
Regulation of CD8+T cells by Zbtb42
$439,956Venuprasad K Poojary · Ut Southwestern Medical Center · R01 · FY2022 · CA
Expression of recombinant Fc receptors by engineered NK cells to enhance cancer cell killing
$439,940Bruce K Walcheck · University Of Minnesota · R01 · FY2021 · CA
DISSECTING OVARIAN CANCER TUMOR-IMMUNE MICROENVIRONMENTS THROUGH 3D IN SITU MOLECULAR PROFILING
$439,922The Chancellor, Masters, And Scholars Of The University Of Cambridge · · FY2022 · Defense Health Agency
CLINICAL THERAPY TRIALS
$439,902Katherine Kurshan Matthay · Children'S Hospital Of Los Angeles · P01 · FY2010 · CA
Function, regulation, and conservation of hypoxia-induced glycolysis condensates
$439,851John Kim · Johns Hopkins University · R35 · FY2024 · GM
Metastatic Clonal Heterogeneity and its Impact on Melanoma Therapeutic Resistance
$439,813Willy Hugo · University Of California Los Angeles · R01 · FY2024 · CA
Project 3: Combinatorial and gene-editing approaches to enhance the efficacy of CAR T cell therapy of multiple myeloma.
$439,749Edward A Stadtmauer · University Of Pennsylvania · P01 · FY2020 · CA
Enhancement of stem cell transplants using CAR.CD30-redirected T lymphocytes
$439,742Barbara Savoldo · Baylor College Of Medicine · R01 · FY2013 · HL
The CXCR3 Chemokine System in Cancer Immunotherapy
$439,649Andrew D Luster · Massachusetts General Hospital · R01 · FY2017 · CA
Engineered hybrid aging model for disease progression
$439,567Pinar Zorlutuna · University Of Notre Dame · R01 · FY2024 · CA
Function, regulation, and conservation of hypoxia-induced glycolysis condensates
$439,512John Kim · Johns Hopkins University · R35 · FY2025 · GM
Project 1: Targeting the PD-1 pathway in HCC
$439,497Ahmed Kaseb · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
The Role of Proteases and Peptides in Cancer Pain
$439,458Brian L Schmidt · New York University · R01 · FY2014 · DE
The Role of Proteases and Peptides in Cancer Pain
$439,458Brian L Schmidt · New York University · R01 · FY2012 · DE
The Metastatic Cascade: Macrophages Lead the Way
$439,400Jeffrey W. Pollard · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · CA
The Metastatic Cascade: Macrophages Lead the Way
$439,400Jeffrey W. Pollard · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · CA
The Metastatic Cascade: Macrophages Lead the Way
$439,399Jeffrey W. Pollard · Albert Einstein College Of Medicine · R01 · FY2015 · CA
Exosome secretion in breast cancer progression
$439,356Alissa M Weaver · Vanderbilt University · R01 · FY2019 · CA
Cell-targeted glutamine antagonists as a novel therapy for lymphoma
$439,350Barbara Stauch Slusher · Johns Hopkins University · R01 · FY2019 · CA
Senescence, Proliferation and Invasion- What is the link?
$439,301Ashani Weeraratna · National Institute On Aging · Z01 · FY2008 · AG
Novel Potent Autophagy Inhibitors for Melanoma
$439,280Jeffrey D Winkler · Wistar Institute · P01 · FY2014 · CA